FDA OK's First Drug for Cooley's Anemia

10:30 EST 8 Nov 2019 | MedPageToday

(MedPage Today) -- WASHINGTON -- The FDA approved luspatercept (Reblozyl) on Friday to reduce the frequency of blood transfusions for adult patients with anemia related to beta thalassemia -- so-called Cooley's anemia. "When patients receive...

Original Article: FDA OK's First Drug for Cooley's Anemia


More From BioPortfolio on "FDA OK's First Drug for Cooley's Anemia"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...